A new type 2 diabetes drug that works differently than all others currently on the market has been approved by the Food and Drug Administration (FDA). Invokana, made by Johnson & Johnson, is a once-a-day medication designed to lower blood sugar by flushing it out in patients’ urine. Analysts believe Invokana could generate $1 billion in annual sales, earning it the coveted “blockbuster drug” status. It is different than other type 2 diabetes medications in that it works by blocking the kidneys from reabsorbing sugar. Older drugs work by reducing the amount of sugar absorbed from food and stored in ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.